Literature DB >> 25583849

Antibodies to the inward rectifying potassium channel 4.1 in multiple sclerosis: different methodologies--conflicting results?

Bernhard Hemmer1.   

Abstract

Entities:  

Keywords:  Autoantibodies; multiple sclerosis (MS); pathology; proteomics

Mesh：

Substances：

Year:  2015        PMID： 25583849     DOI： 10.1177/1352458514564493

Source DB:  PubMed          Journal:  Mult Scler        ISSN： 1352-4585            Impact factor:   6.312


× No keyword cloud information.
  7 in total

Review 1.  Multiple sclerosis.

Authors:  Massimo Filippi; Amit Bar-Or; Fredrik Piehl; Paolo Preziosa; Alessandra Solari; Sandra Vukusic; Maria A Rocca
Journal:  Nat Rev Dis Primers       Date:  2018-11-08       Impact factor: 52.329

Review 2.  Some recent advances in multiple sclerosis.

Authors:  Claire McCarthy; John Thorpe
Journal:  J Neurol       Date:  2016-04-25       Impact factor: 4.849

Review 3.  Pattern Recognition of the Multiple Sclerosis Syndrome.

Authors:  Rana K Zabad; Renee Stewart; Kathleen M Healey
Journal:  Brain Sci       Date:  2017-10-24

4.  Evaluation of KIR4.1 as an Immune Target in Multiple Sclerosis.

Authors:  Anne Chastre; David A Hafler; Kevin C O'Connor
Journal:  N Engl J Med       Date:  2016-04-14       Impact factor: 91.245

5.  Humoral Responses to Diverse Autoimmune Disease-Associated Antigens in Multiple Sclerosis.

Authors:  Kishore Malyavantham; Bianca Weinstock-Guttman; Lakshmanan Suresh; Robert Zivadinov; Thomas Shanahan; Darlene Badgett; Murali Ramanathan
Journal:  PLoS One       Date:  2015-06-11       Impact factor: 3.240

Review 6.  B Cells and Autoantibodies in Multiple Sclerosis.

Authors:  Anne-Katrin Pröbstel; Nicholas S R Sanderson; Tobias Derfuss
Journal:  Int J Mol Sci       Date:  2015-07-21       Impact factor: 5.923

Review 7.  Anti-Kir4.1 Antibodies in Multiple Sclerosis: Specificity and Pathogenicity.

Authors:  Michie Imamura; Osamu Higuchi; Yasuhiro Maeda; Akihiro Mukaino; Mitsuharu Ueda; Hidenori Matsuo; Shunya Nakane
Journal:  Int J Mol Sci       Date:  2020-12-17       Impact factor: 5.923
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.